Pharmstandard
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 2003 |
| Headquarters | Dolgoprudny, Russia |
Area served | Worldwide |
Key people | Viktor Kharitonin (Chairman) Igor Krylov (CEO) |
| Products | Remedies |
| Revenue | $638 million (2017) |
| $231 million (2016) | |
| $119 million (2016) | |
| Total assets | $1.41 billion (2016) |
| Total equity | $936 million (2016) |
Number of employees | 6,450 (2015) |
| Website | pharmstd.com |
JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational pharmaceutical company. It is headquartered in Dolgoprudny, Moscow Oblast.
Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.
The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.